282 related articles for article (PubMed ID: 8230497)
21. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
Caudarella R; Vescini F
Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
[TBL] [Abstract][Full Text] [Related]
22. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones.
Alvarez Arroyo MV; Traba ML; Rapado A
Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
Pak CY; Peterson R
Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975
[TBL] [Abstract][Full Text] [Related]
24. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
25. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
[TBL] [Abstract][Full Text] [Related]
26. Effects of citrate on the different phases of calcium oxalate crystallization.
Tiselius HG; Berg C; Fornander AM; Nilsson MA
Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
[TBL] [Abstract][Full Text] [Related]
27. Alkaline citrate in prevention of recurrent calcium oxalate stones.
Berg C
Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
[TBL] [Abstract][Full Text] [Related]
28. Successful management of uric acid nephrolithiasis with potassium citrate.
Pak CY; Sakhaee K; Fuller C
Kidney Int; 1986 Sep; 30(3):422-8. PubMed ID: 3784284
[TBL] [Abstract][Full Text] [Related]
29. Citrate and renal calculi.
Pak CY
Miner Electrolyte Metab; 1987; 13(4):257-66. PubMed ID: 3306318
[TBL] [Abstract][Full Text] [Related]
30. Long-term effects of potassium citrate therapy on the formation of new stones in groups of recurrent stone formers with hypocitraturia.
Whalley NA; Meyers AM; Martins M; Margolius LP
Br J Urol; 1996 Jul; 78(1):10-4. PubMed ID: 8795392
[TBL] [Abstract][Full Text] [Related]
31. Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers.
Fuselier HA; Ward DM; Lindberg JS; Allen JM; Husserl FE; Marcucci PA; Cole FE; Turnipseed J; Alam J; Kok DJ
Urology; 1995 Jun; 45(6):942-6. PubMed ID: 7771027
[TBL] [Abstract][Full Text] [Related]
32. Hypocitraturia in calcium nephrolithiasis.
Rudman D; Kutner MH; Redd SC; Waters WC; Gerron GG; Bleier J
J Clin Endocrinol Metab; 1982 Dec; 55(6):1052-7. PubMed ID: 7130336
[TBL] [Abstract][Full Text] [Related]
33. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
[TBL] [Abstract][Full Text] [Related]
34. Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate.
Preminger GM; Sakhaee K; Pak CY
J Urol; 1988 Feb; 139(2):240-2. PubMed ID: 3339718
[TBL] [Abstract][Full Text] [Related]
35. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
[TBL] [Abstract][Full Text] [Related]
36. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial.
Soygür T; Akbay A; Küpeli S
J Endourol; 2002 Apr; 16(3):149-52. PubMed ID: 12028622
[TBL] [Abstract][Full Text] [Related]
37. Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis.
Song Y; Hernandez N; Shoag J; Goldfarb DS; Eisner BH
Urolithiasis; 2016 Apr; 44(2):145-8. PubMed ID: 26582172
[TBL] [Abstract][Full Text] [Related]
38. Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.
Doizi S; Poindexter JR; Pearle MS; Blanco F; Moe OW; Sakhaee K; Maalouf NM
J Urol; 2018 Dec; 200(6):1278-1284. PubMed ID: 30036516
[TBL] [Abstract][Full Text] [Related]
39. Inhibition by sodium-potassium citrate (CG-120) of calcium oxalate crystal growth on to kidney stone fragments obtained from extracorporeal shock wave lithotripsy.
Suzuki K; Tsugawa R; Ryall RL
Br J Urol; 1991 Aug; 68(2):132-7. PubMed ID: 1884137
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of stone formers treated with a low dose of sodium potassium citrate.
Jendle-Bengten C; Tiselius HG
Scand J Urol Nephrol; 2000 Feb; 34(1):36-41. PubMed ID: 10757268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]